06.01.2013 Views

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

– 7 –<br />

Summary of Findings<br />

field trials from 1996 to 1999, the transgenic papaya exhibited high degrees of protection against<br />

PRSV in the Republic of China. Un<strong>for</strong>tunately, 18 months after planting in the fourth field trial,<br />

unexpected symptoms of severe distortion on fully expanded leaves, stunning on apex, watersoaking<br />

on petioles and stem, and yellow ringspot on fruit were noticed on PRSV CP-transgenic<br />

papaya plants. The causal agent was distinguished from PRSV by host reactions and serological<br />

properties and later identified as Papaya leaf distortion mosaic virus (PLDMV), a potyvirus<br />

which originated from Okinawa, Japan, in 1954. All PRSV CP-transgenic papaya lines were susceptible<br />

to PLDMV infection when evaluated under greenhouse conditions. There<strong>for</strong>e, in the Republic<br />

of China PLDMV will be considered a serious threat to papaya production once PRSV<br />

CP-transgenic papaya is widely used <strong>for</strong> the control of PRSV.<br />

In order to control two or more viruses, transgenic plants with multiple resistances have<br />

been generated by combining the entire CP gene of more than one virus, with each gene driven<br />

by a promoter and a terminator. Transgenic lines expressing these chimeric CP constructs were<br />

resistant to the corresponding viruses and protected from mixed infection such as Cucumber<br />

mosaic virus, Watermelon mosaic virus, and Zucchini yellow mosaic virus. Furthermore, transgenic<br />

plants with resistance to a potyvirus and a tospovirus can be obtained through the PTGS<br />

mechanism by fusing a segment of tospoviral N gene to a segment of potyviral CP gene. This<br />

strategy was used to develop double resistance to both PRSV and PLDMV. An untranslatable<br />

chimeric construct that contained the truncated PRSV CP and PLDMV CP genes was then transferred<br />

to papaya. Through the PTGS mechanism, transgenic papaya plants carrying this chimeric<br />

transgene indeed conferred resistance against both PRSV and PLDMV under greenhouse conditions.<br />

These transgenic papaya plants with double resistance are considered to have great potential<br />

<strong>for</strong> the control of PRSV and PLDMV in Taiwan. In four-year field trials, a super PRSV<br />

strain 5-19 which infected transgenic papaya lines was found. The breakdown of the transgenic<br />

resistance by a strong gene-silencing suppressor of a super strain has a strong impact on the application<br />

of transgenic crops <strong>for</strong> virus control. A chimeric construct targeting at multiple viral<br />

genes, including the gene determining viral virulence and gene silencing suppression, such as the<br />

HC-Pro gene of a potyvirus, may minimize the chance of emergence of a super virus <strong>for</strong> overcoming<br />

the transgenic resistance.<br />

Commercial-scale Production of Valuable Plant Biomass and Secondary Metabolites Using<br />

a Bioreactor System<br />

Plants are a de facto biological factory that produces an immense array of fine chemical<br />

compounds highly valued in pharmaceutical, food, and bioenergy industries. Thus it is of huge<br />

business interest to grow plant cells, tissues, and even entire organisms at commercial scales.<br />

Having proven its medicinal superiority in traditional medicine, Korean Mountain Ginseng<br />

(KMG) has a high market value among Korean people that has stimulated much interest in<br />

producing its biomass <strong>for</strong> commercialization. However, there have been only a few success<br />

stories of plant cultures at the commercial scale. Recently, a group at VitroSys Inc. successfully<br />

implemented an industrial-scale bioreactor system <strong>for</strong> the commercial production of Korean<br />

Mountain Ginseng (Panax ginseng C. A. Meyer). The bioreactor system holds a promising<br />

future <strong>for</strong> applications, such as the large-scale production of diverse secondary metabolites from<br />

plant tissues.<br />

Commercialization of <strong>Agricultural</strong> Crop <strong>Biotechnology</strong> Products<br />

High-quality seed of crop cultivars with the desirable genetic background still <strong>for</strong>m the<br />

foundation <strong>for</strong> farming. <strong>Biotechnology</strong> offers the best opportunity to meet the challenge of improving<br />

on the potential in seeds and also of providing the enabling knowledge to express that<br />

potential. Crops developed through biotechnology are produced by the stable insertion of one or<br />

a few well-defined genes into the genome of a plant. The gene(s) produce one or a few proteins<br />

that confer the trait of interest (e.g., insect resistance). Of the thousands of individual plants that

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!